The board (the "Board") of directors (the "Directors") of MicroPort CardioFlow Medtech Corporation (the "Company") announced that Mr. Zhao Liang ("Mr. Zhao")
has been appointed as an executive Director and a director of Shanghai MicroPort CardioFlow Medtech Co. Ltd., a subsidiary of company, with effect from May 26, 2022. The biographical details of Mr. Zhao are set out as follows: Mr. Zhao, aged 43, was appointed as First Vice President of Total Solutions responsible for
promotion of the Company's total solutions of structural heart diseases on October 1, 2021 when he joined Group. Prior to joining us, he was First Vice President of China Regional Sales and Marketing of Interventional Cardiology of MicroPort Scientific Corporation and its subsidiaries (the "MicroPort Group"). He joined MicroPort Group in 2006 and has over 15 years of experience in the promotion and sales management of cardiovascular medical devices, and possesses expertise in promotion strategy, market and channel expansion, team management, etc. Mr. Zhao obtained his bachelor's degree in economic management from Nanjing University in China in 2002.